Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression - PubMed (original) (raw)

Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression

W D Lo et al. Hum Gene Ther. 1999.

Abstract

Adeno-associated virus (AAV) is a promising vector for central nervous system (CNS) gene transfer, but a number of issues must be addressed if AAV is to be used for widespread delivery throughout the CNS. Our aim was to test the effect of dose, route of delivery, and hydroxyurea treatment on brain expression of beta-galactosidase activity after cerebral inoculation with an rAAV-lacZ vector (rAAV-beta-gal). We also wished to test whether an immune response appeared against the vector and the transgene product. We found in BALB/c mice that beta-Gal expression increased during the first 2 months after inoculation, then decreased slightly by 4 months, and continued out to 6, 12, and 15 months in single animals. Cerebral injection produced localized beta-Gal expression that did not diffuse to other regions despite a fivefold increase in injection volume. Intraventricular injection resulted in negligible transduction. Antibodies to AAV capsid protein and beta-Gal appeared at low levels at 2 and 4 months, but correlated poorly with beta-Gal expression and did not prevent readministration of rAAV-beta-gal. Hydroxyurea treatment did not result in increased transduction in vivo. We conclude that our study confirms rAAV vectors as having considerable potential for CNS gene transfer; however, several important problems must be addressed if this vector system is to be used for long-term transduction of the entire brain. Sustained, regulatable expression will be needed if rAAV is to be used in the treatment of chronic CNS disease. The difficulty in delivering AAV to diverse regions of the brain is an important problem that must be overcome if these vectors are to be used for anything beyond localized transduction.

PubMed Disclaimer

Cited by

Gene therapy for metachromatic leukodystrophy.
Rosenberg JB, Kaminsky SM, Aubourg P, Crystal RG, Sondhi D. Rosenberg JB, et al. J Neurosci Res. 2016 Nov;94(11):1169-79. doi: 10.1002/jnr.23792. J Neurosci Res. 2016. PMID: 27638601 Free PMC article. Review.
Pre-immunization with an intramuscular injection of AAV9-human erythropoietin vectors reduces the vector-mediated transduction following re-administration in rat brain.
Yang C, Yang WH, Chen SS, Ma BF, Li B, Lu T, Qu TY, Klein RL, Zhao LR, Duan WM. Yang C, et al. PLoS One. 2013 May 8;8(5):e63876. doi: 10.1371/journal.pone.0063876. Print 2013. PLoS One. 2013. PMID: 23667683 Free PMC article.
Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.
Kirik D, Rosenblad C, Bjorklund A, Mandel RJ. Kirik D, et al. J Neurosci. 2000 Jun 15;20(12):4686-700. doi: 10.1523/JNEUROSCI.20-12-04686.2000. J Neurosci. 2000. PMID: 10844038 Free PMC article.
AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models.
Albert K, Voutilainen MH, Domanskyi A, Airavaara M. Albert K, et al. Genes (Basel). 2017 Feb 8;8(2):63. doi: 10.3390/genes8020063. Genes (Basel). 2017. PMID: 28208742 Free PMC article. Review.
Rapid, long-term labeling of cells in the developing and adult rodent visual cortex using double-stranded adeno-associated viral vectors.
Lowery RL, Zhang Y, Kelly EA, Lamantia CE, Harvey BK, Majewska AK. Lowery RL, et al. Dev Neurobiol. 2009 Sep 1;69(10):674-88. doi: 10.1002/dneu.20735. Dev Neurobiol. 2009. PMID: 19551873 Free PMC article.

Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression - PubMed (original) (raw)